\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ no\\ concerning\\ mass\\ or\\ enhancement\\ was\\ demonstrated\\.\\ \\ a\\ previously\\ performed\\ ultrasound\\ of\\ the\\ breast\\ demonstrated\\ no\\ underlying\\ mass\\ in\\ the\\ periareolar\\ region\\ of\\ patient\\'s\\ pain\\.\\ \\ given\\ these\\ findings\\ the\\ mr\\ fits\\ a\\ birads\\ category\\ 2\\ for\\ benign\\ findings\\.\ \(0\)\
\-\ multiple\\ well\\ circumscribed\\ foci\\ of\\ nonenhancing\\,\\ increased\\ t2\\ signal\\ on\\ stir\\ and\\ decreased\\ signal\\ on\\ t2\\ fat\\ suppressed\\ sequences\\ in\\ the\\ breasts\\ without\\ skin\\ thickening\\.\ \(0\)\
\-\ no\\ concerning\\ areas\\ of\\ enhancement\\ on\\ post\\ gadolinium\\ sequences\\.\ \(0\)\
\-\ siliconomas\\:\\ \\ silicone\\ granulomas\\ from\\ direct\\ intramammary\\ silicone\\ injection\\ breast\\ augmentation\ \(0\)\
\-\ injected\\ silicone\ \(1\)\
\-\ extracapsular\\ silicone\\ rupture\ \(1\)\
\-\ 59\\ year\\ old\\ asian\\ woman\\ with\\ history\\ of\\ breast\\ augmentation\\ and\\ subareolar\\ pain\\.\ \(0\)\
\-\ imaging\\ of\\ silicone\\ has\\ characteristic\\ signal\\ properties\\ with\\ increased\\ signal\\ on\\ t2wi\\,\\ decreased\\ signal\\ on\\ fat\\ suppressed\\ t2wi\\ and\\ t1wi\\.\ \(0\)\
\-\ silicone\\ breast\\ injections\\ are\\ common\\ in\\ asia\\ despite\\ being\\ outlawed\\ in\\ the\\ united\\ states\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ silicone\\:\\ 0\\.5570559949317194\ \(0\)\
\-\ breast\\:\\ 0\\.23594861895239644\ \(0\)\
\-\ signal\\:\\ 0\\.23023600027669697\ \(0\)\
\-\ augmentation\\:\\ 0\\.20058748487778413\ \(0\)\
\-\ suppressed\\:\\ 0\\.18676017950987472\ \(0\)\
\-\ t2wi\\:\\ 0\\.1737881963244605\ \(0\)\
\-\ concerning\\:\\ 0\\.1558390948446796\ \(0\)\
\-\ sequences\\:\\ 0\\.12996584599001273\ \(0\)\
\-\ outlawed\\:\\ 0\\.12990508159439978\ \(0\)\
\-\ on\\:\\ 0\\.12266486423633352\ \(0\)\
\-\ periareolar\\:\\ 0\\.12003463520923054\ \(0\)\
\-\ siliconomas\\:\\ 0\\.11685706120876517\ \(0\)\
\-\ intramammary\\:\\ 0\\.11685706120876517\ \(0\)\
\-\ birads\\:\\ 0\\.1101641888240613\ \(0\)\
\-\ subareolar\\:\\ 0\\.10848695320782516\ \(0\)\
\-\ properties\\:\\ 0\\.10698661482359592\ \(0\)\
\-\ asia\\:\\ 0\\.10562939366465035\ \(0\)\
\-\ fits\\:\\ 0\\.10439034782335861\ \(0\)\
\-\ extracapsular\\:\\ 0\\.10439034782335861\ \(0\)\
\-\ fat\\:\\ 0\\.1010606321807182\ \(0\)\
\-\ decreased\\:\\ 0\\.10063154552420839\ \(0\)\
\-\ demonstrated\\:\\ 0\\.09984402747574674\ \(0\)\
\-\ of\\:\\ 0\\.09537856967450466\ \(0\)\
\-\ nonenhancing\\:\\ 0\\.095125952222317\ \(0\)\
\-\ enhancement\\:\\ 0\\.0935095998017412\ \(0\)\
\-\ t2\\:\\ 0\\.09346817421174299\ \(0\)\
\-\ category\\:\\ 0\\.09338008975493736\ \(0\)\
\-\ asian\\:\\ 0\\.09284266582195323\ \(0\)\
\-\ stir\\:\\ 0\\.09182508702699121\ \(0\)\
\-\ granulomas\\:\\ 0\\.09134232743772398\ \(0\)\
\-\ injections\\:\\ 0\\.08955999876846679\ \(0\)\
\-\ breasts\\:\\ 0\\.08874606043748669\ \(0\)\
\-\ injected\\:\\ 0\\.08874606043748669\ \(0\)\
\-\ t1wi\\:\\ 0\\.08874606043748669\ \(0\)\
\-\ united\\:\\ 0\\.08874606043748669\ \(0\)\
\-\ increased\\:\\ 0\\.08785106743796613\ \(0\)\
\-\ the\\:\\ 0\\.08104203335005673\ \(0\)\
\-\ in\\:\\ 0\\.08082994162326645\ \(0\)\
\-\ findings\\:\\ 0\\.08018091378361591\ \(0\)\
\-\ no\\:\\ 0\\.0792455980757709\ \(0\)\
\-\ 59\\:\\ 0\\.07702365177706101\ \(0\)\
\-\ direct\\:\\ 0\\.0716014346673855\ \(0\)\
\-\ states\\:\\ 0\\.07136605667946395\ \(0\)\
\-\ injection\\:\\ 0\\.07068240328338435\ \(0\)\
\-\ despite\\:\\ 0\\.07068240328338435\ \(0\)\
\-\ gadolinium\\:\\ 0\\.06768395169565565\ \(0\)\
\-\ foci\\:\\ 0\\.06639242866501492\ \(0\)\
\-\ underlying\\:\\ 0\\.06631035325595003\ \(0\)\
\-\ rupture\\:\\ 0\\.0656702435126268\ \(0\)\
\-\ characteristic\\:\\ 0\\.0656702435126268\ \(0\)\
\-\ previously\\:\\ 0\\.06520836375708766\ \(0\)\
\-\ circumscribed\\:\\ 0\\.06290545331417359\ \(0\)\
\-\ mass\\:\\ 0\\.06205568298010481\ \(0\)\
\-\ skin\\:\\ 0\\.06042780910104046\ \(0\)\
\-\ pain\\:\\ 0\\.05813444767859766\ \(0\)\
\-\ being\\:\\ 0\\.056604533491040734\ \(0\)\
\-\ given\\:\\ 0\\.05587825486891297\ \(0\)\
\-\ benign\\:\\ 0\\.05579979712745757\ \(0\)\
\-\ thickening\\:\\ 0\\.05526237319447343\ \(0\)\
\-\ areas\\:\\ 0\\.055149803090059145\ \(0\)\
\-\ mr\\:\\ 0\\.05255976669331272\ \(0\)\
\-\ and\\:\\ 0\\.05035579836083649\ \(0\)\
\-\ ultrasound\\:\\ 0\\.050104413868210275\ \(0\)\
\-\ region\\:\\ 0\\.04858834931556743\ \(0\)\
\-\ performed\\:\\ 0\\.04805616550924821\ \(0\)\
\-\ common\\:\\ 0\\.04606693677929066\ \(0\)\
\-\ these\\:\\ 0\\.045870789820615446\ \(0\)\
\-\ post\\:\\ 0\\.04420004909345483\ \(0\)\
\-\ without\\:\\ 0\\.042845978038283015\ \(0\)\
\-\ imaging\\:\\ 0\\.04268932030814348\ \(0\)\
\-\ woman\\:\\ 0\\.04230505403300616\ \(0\)\
\-\ multiple\\:\\ 0\\.03973155289541356\ \(0\)\
\-\ well\\:\\ 0\\.03933215650510472\ \(0\)\
\-\ has\\:\\ 0\\.037103676461439625\ \(0\)\
\-\ from\\:\\ 0\\.03226126810967915\ \(0\)\
\-\ with\\:\\ 0\\.0318118527823859\ \(0\)\
\-\ history\\:\\ 0\\.031034712440270756\ \(0\)\
\-\ are\\:\\ 0\\.030823239636200407\ \(0\)\
\-\ was\\:\\ 0\\.028309596022051117\ \(0\)\
\-\ or\\:\\ 0\\.02825860714861096\ \(0\)\
\-\ patient\\:\\ 0\\.026420168838330576\ \(0\)\
\-\ year\\:\\ 0\\.025033607693941543\ \(0\)\
\-\ for\\:\\ 0\\.02462030856445668\ \(0\)\
\-\ old\\:\\ 0\\.02404092898453761\ \(0\)\
